| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MetaVia Inc. | Chief Financial Officer | Common Stock | 30,734 | $18,440 | $0.6000 | 23 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MTVA | MetaVia Inc. | 23 Jan 2026 | 1 | $0 | 4 | Chief Financial Officer | 27 Jan 2026, 16:02 |
| MTVA | MetaVia Inc. | 12 Aug 2025 | 1 | $0 | 4 | Chief Financial Officer | 13 Aug 2025, 16:36 |
| MTVA | MetaVia Inc. | 04 Jun 2025 | 1 | +$9,940 | 4 | Chief Financial Officer | 04 Jun 2025, 16:01 |
| MTVA | MetaVia Inc. | 01 Mar 2025 | 1 | -$4,989 | 4 | Chief Financial Officer | 04 Mar 2025, 16:01 |
| MTVA | NeuroBo Pharmaceuticals, Inc. | 01 Mar 2024 | 1 | $0 | 4 | Chief Financial Officer | 04 Mar 2024, 21:20 |
| MTVA | NeuroBo Pharmaceuticals, Inc. | 27 Oct 2023 | 0 | $0 | 3 | Acting Chief Financial Officer | 30 Oct 2023, 16:31 |